Literature DB >> 20181741

Double bromodomain protein BET-1 and MYST HATs establish and maintain stable cell fates in C. elegans.

Yukimasa Shibata1, Hisako Takeshita, Noriko Sasakawa, Hitoshi Sawa.   

Abstract

The maintenance of cell fate is important for normal development and tissue homeostasis. Epigenetic mechanisms, including histone modifications, are likely to play crucial roles in cell-fate maintenance. However, in contrast to the established functions of histone methylation, which are mediated by the polycomb proteins, the roles of histone acetylation in cell-fate maintenance are poorly understood. Here, we show that the C. elegans acetylated-histone-binding protein BET-1 is required for the establishment and maintenance of stable fate in various lineages. In most bet-1 mutants, cells adopted the correct fate initially, but at later stages they often transformed into a different cell type. By expressing BET-1 at various times in development and examining the rescue of the Bet-1 phenotype, we showed that BET-1 functions both at the time of fate acquisition, to establish a stable fate, and at later stages, to maintain the established fate. Furthermore, the disruption of the MYST HATs perturbed the subnuclear localization of BET-1 and caused bet-1-like phenotypes, suggesting that BET-1 is recruited to its targets through acetylated histones. Our results therefore indicate that histone acetylation plays a crucial role in cell-fate maintenance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20181741     DOI: 10.1242/dev.042812

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  13 in total

1.  The homeodomain protein hmbx-1 maintains asymmetric gene expression in adult C. elegans olfactory neurons.

Authors:  Bluma J Lesch; Cornelia I Bargmann
Journal:  Genes Dev       Date:  2010-08-15       Impact factor: 11.361

2.  Maintenance of neuronal laterality in Caenorhabditis elegans through MYST histone acetyltransferase complex components LSY-12, LSY-13 and LIN-49.

Authors:  M Maggie O'Meara; Feifan Zhang; Oliver Hobert
Journal:  Genetics       Date:  2010-10-05       Impact factor: 4.562

Review 3.  BET domain co-regulators in obesity, inflammation and cancer.

Authors:  Anna C Belkina; Gerald V Denis
Journal:  Nat Rev Cancer       Date:  2012-06-22       Impact factor: 60.716

4.  Maintenance of cell fates through acetylated histone and the histone variant H2A.z in C. elegans.

Authors:  Yukimasa Shibata; Kiyoji Nishiwaki
Journal:  Worm       Date:  2014-05-08

5.  Direct in vivo cellular reprogramming involves transition through discrete, non-pluripotent steps.

Authors:  Jai Prakash Richard; Steven Zuryn; Nadine Fischer; Valeria Pavet; Nadège Vaucamps; Sophie Jarriault
Journal:  Development       Date:  2011-03-09       Impact factor: 6.868

Review 6.  An emerging role for bromodomain-containing proteins in chromatin regulation and transcriptional control of adipogenesis.

Authors:  Gerald V Denis; Barbara S Nikolajczyk; Gavin R Schnitzler
Journal:  FEBS Lett       Date:  2010-05-21       Impact factor: 4.124

7.  The nuclear ubiquitin ligase adaptor SPOP is a conserved regulator of C9orf72 dipeptide toxicity.

Authors:  Carley Snoznik; Valentina Medvedeva; Jelena Mojsilovic-Petrovic; Paige Rudich; James Oosten; Robert G Kalb; Todd Lamitina
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-30       Impact factor: 11.205

8.  Evidence of a MOF histone acetyltransferase-containing NSL complex in C. elegans.

Authors:  Matthew Hoe; Hannah R Nicholas
Journal:  Worm       Date:  2014-12-31

9.  Epe1 recruits BET family bromodomain protein Bdf2 to establish heterochromatin boundaries.

Authors:  Jiyong Wang; Xavier Tadeo; Haitong Hou; Patricia G Tu; James Thompson; John R Yates; Songtao Jia
Journal:  Genes Dev       Date:  2013-09-01       Impact factor: 11.361

10.  A nervous system-specific subnuclear organelle in Caenorhabditis elegans.

Authors:  Kenneth Pham; Neda Masoudi; Eduardo Leyva-Díaz; Oliver Hobert
Journal:  Genetics       Date:  2021-03-03       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.